NEW - Immuno-Oncology Services
Celentyx have developed a series of in vitro assays to support early progression of immuno-oncology therapies and at the same time provide proof of concept in man, mechanism of action data and, where required, comparison of efficacy with competitor therapeutics.
Please click here for further information.
Celentyx have developed a series of in vitro assays to support early progression of immuno-oncology therapies and at the same time provide proof of concept in man, mechanism of action data and, where required, comparison of efficacy with competitor therapeutics.
Please click here for further information.
Celentyx Ltd offers clients Bespoke Services and Expert Project Management capabilities. Learn more...
|
|
Professor John Gordon, Co-founder & CSO, introduces Celentyx Ltd's capabilities to investigate the human immune system.
|